Genome-Wide Assessment of the Carriers Involved In The Cellular Uptake of Drugs: A Model System in Yeast
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
Background: The uptake of drugs into cells has traditionally been considered to be predominantly via passive diffusion through the bilayer portion of the cell membrane. The recent recognition that drug uptake is mostly carrier-mediated raises the question of which drugs use which carriers.
Results: To answer this, we have constructed a chemical genomics platform built upon the yeast gene deletion collection, using competition experiments in batch fermenters and robotic automation of cytotoxicity screens, including protection by ‘natural’ substrates. Using these, we tested 26 different drugs and identified the carriers required for 18 of the drugs to gain entry into yeast cells.
Conclusions: As well as providing a useful platform technology, these results further substantiate the notion that the cellular uptake of pharmaceutical drugs normally occurs via carrier-mediated transport and indicates that establishing the identity and tissue distribution of such carriers should be a major consideration in the design of
safe and effective drugs.
Authors: Karin Lanthaler1,2,3†, Elizabeth Bilsland4†, Paul D Dobson1,2, Harry J Moss4, Pinar Pir3,4, Douglas B Kell1,2 and
Stephen G Oliver3,4*
Have Your Say
Rate this feature and give us your feedback in the comments section below
* Correspondence: email@example.com
† Contributed equally
3Faculty of Life Sciences, University of Manchester, Michael Smith Building,
Oxford Road, Manchester, M13 9PT, UK
Full list of author information is available at the end of the article
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.